Won-sik Shin
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling.
Journal: International journal of molecular sciences
Published: June 22, 2023
Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma.
Journal: International journal of molecular sciences
Published: August 19, 2022
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function.
Journal: Cancers
Published: August 12, 2022
PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.
Journal: International journal of molecular sciences
Published: January 27, 2022
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
Journal: Scientific reports
Published: March 01, 2018
PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.
Journal: Journal of cellular biochemistry
Published: August 06, 2016
Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis.
Journal: Biochimica et biophysica acta
Published: February 10, 2015
Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.
Journal: Cancer science
Published: December 18, 2012
The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.
Journal: The Journal of biological chemistry
Published: June 06, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026